Posted 18 August 2019
In May 2019, the Therapeutic Goods Administration (TGA – Australia) commenced work on a sector-wide compliance activity relating to the advertising of ‘bioresonance’ devices, which are sometimes mistakenly promoted as ‘biofeedback’ devices. This sector has been identified as having a high rate of advertising non-compliance, with widespread advertising. The advertising of bioresonance has been the subject of previous regulatory compliance actions.
(Editor: Beamer, Scio and Quantum SCIO-EPFX devices are included in this category)
Bioresonance is based on the belief that human beings emit electromagnetic waves, which can only be measured by bioresonance devices. Advertisers claim these devices can measure these waves to detect illness in the human body as well as sending ‘rehabilitated bad’ waves to the patient to alleviate illness.
The TGA is currently investigating the scientific credibility relating to the diagnostic and therapeutic use of these devices. The TGA is also working … Read the rest